138 related articles for article (PubMed ID: 36520380)
21. Stereotactic radiosurgery for brain metastases from newly diagnosed small cell lung cancer: practice patterns and outcomes.
Jiang W; Haque W; Verma V; Butler B; Teh BS
Acta Oncol; 2019 Apr; 58(4):491-498. PubMed ID: 30676131
[TBL] [Abstract][Full Text] [Related]
22. High Biologically Effective Dose Radiotherapy for Brain Metastases May Improve Survival and Decrease Risk for Local Relapse Among Patients With Small-Cell Lung Cancer: A Propensity-Matching Analysis.
Zhuang QY; Li JL; Lin FF; Lin XJ; -Lin H; -Wang Y; -Lin Y; Huang YX; Zhang XQ; Tang LR; Wu JX
Cancer Control; 2020; 27(2):1073274820936287. PubMed ID: 32614270
[TBL] [Abstract][Full Text] [Related]
23. Management and Outcomes of Newly Diagnosed Non-Small Cell Lung Cancer Patients with Brain Metastases: A Real-World Study in Japan.
Yoshida H; Kim YH; Iwatsubo S; Sakaguchi C; Sakamori Y; Nagai H; Ozasa H; Mio T; Hirai T
Oncology; 2020; 98(7):460-467. PubMed ID: 32222702
[TBL] [Abstract][Full Text] [Related]
24. Histogram Analysis of ADC Maps for Differentiating Brain Metastases From Different Histological Types of Lung Cancers.
Bozdağ M; Er A; Çinkooğlu A
Can Assoc Radiol J; 2021 May; 72(2):271-278. PubMed ID: 32602365
[TBL] [Abstract][Full Text] [Related]
25. Real-world impact of brain metastases on healthcare utilization and costs in patients with non-small cell lung cancer treated with EGFR-TKIs in the US.
Kong AM; Pavilack M; Huo H; Shenolikar R; Moynihan M; Marchlewicz EH; Chebili-Larson C; Min S; Subramaniam DS
J Med Econ; 2021; 24(1):328-338. PubMed ID: 33576296
[TBL] [Abstract][Full Text] [Related]
26. Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?
Hendriks LE; Bootsma GP; de Ruysscher DK; Scheppers NA; Hofman PA; Brans BT; Dingemans AM
Lung Cancer; 2013 Jun; 80(3):293-7. PubMed ID: 23518381
[TBL] [Abstract][Full Text] [Related]
27. Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer.
Lee HY; Chung JK; Jeong JM; Lee DS; Kim DG; Jung HW; Lee MC
Ann Nucl Med; 2008 May; 22(4):281-6. PubMed ID: 18535878
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal Brain Changes Associated with Prophylactic Cranial Irradiation in Lung Cancer.
Simó M; Vaquero L; Ripollés P; Gurtubay-Antolin A; Jové J; Navarro A; Cardenal F; Bruna J; Rodríguez-Fornells A
J Thorac Oncol; 2016 Apr; 11(4):475-86. PubMed ID: 26804637
[TBL] [Abstract][Full Text] [Related]
29. Predicting brain metastases for non-small cell lung cancer based on magnetic resonance imaging.
Yin G; Li C; Chen H; Luo Y; Orlandini LC; Wang P; Lang J
Clin Exp Metastasis; 2017 Feb; 34(2):115-124. PubMed ID: 28101700
[TBL] [Abstract][Full Text] [Related]
30. Tumour volume changes assessed with high-quality KVCT in lung cancer patients undergoing concurrent chemoradiotherapy.
Lee YH; Kim YS; Lee HC; Lee SW; Kang YN; Kang JH; Hong SH; Kim YK; Kim SJ; Ahn MI; Han DH; Yoo IR; Park JG; Sung SW; Lee KY
Br J Radiol; 2015 Aug; 88(1052):20150156. PubMed ID: 26055505
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation.
Ji Z; Bi N; Wang J; Hui Z; Xiao Z; Feng Q; Zhou Z; Chen D; Lv J; Liang J; Fan C; Liu L; Wang L
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):330-7. PubMed ID: 24725335
[TBL] [Abstract][Full Text] [Related]
32. Is stereotactic radiosurgery a rational treatment option for brain metastases from small cell lung cancer? A retrospective analysis of 70 consecutive patients.
Yomo S; Hayashi M
BMC Cancer; 2015 Mar; 15():95. PubMed ID: 25879433
[TBL] [Abstract][Full Text] [Related]
33. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).
Berghoff AS; Ricken G; Wilhelm D; Rajky O; Widhalm G; Dieckmann K; Birner P; Bartsch R; Preusser M
J Neurooncol; 2016 Oct; 130(1):19-29. PubMed ID: 27436101
[TBL] [Abstract][Full Text] [Related]
34. Applicability of the lung-molGPA index in non-small cell lung cancer patients with different gene alterations and brain metastases.
Chen K; Yu X; Zhang F; Xu Y; Zhang P; Huang Z; Fan Y
Lung Cancer; 2018 Nov; 125():8-13. PubMed ID: 30429042
[TBL] [Abstract][Full Text] [Related]
35. AXL-GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases.
Wu X; Ma W; Zhou Q; Yan H; Lim ZF; Huang M; Deng C; Yu X; Su H; Komo S; Yang H; Zhang X; Wen S; Zhang Z; Ma PC
J Cancer Res Clin Oncol; 2017 Oct; 143(10):1947-1957. PubMed ID: 28551766
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical characteristics of brain metastases and corresponding primary lung cancer.
Marinova Marinova D; Vitkov Mekov E; Gosheva Dimitrova D; Todorov Titorenkov P; Martinov Mihailov M; Slavov Nachev S; Milosheva Youroukova V; Temelkov Kostadinov D; Georgieva Slavova Y
J BUON; 2019; 24(4):1626-1637. PubMed ID: 31646818
[TBL] [Abstract][Full Text] [Related]
37. Clinical Significance of PD-L1 Expression in Brain Metastases from Non-small Cell Lung Cancer.
Takamori S; Toyokawa G; Okamoto I; Takada K; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Mukae N; Hirai F; Tagawa T; Oda Y; Iwaki T; Iihara K; Nakanishi Y; Maehara Y
Anticancer Res; 2018 Jan; 38(1):553-557. PubMed ID: 29277823
[TBL] [Abstract][Full Text] [Related]
38. Gefitinib alone or with concomitant whole brain radiotherapy for patients with brain metastasis from non-small-cell lung cancer: a retrospective study.
Zeng YD; Zhang L; Liao H; Liang Y; Xu F; Liu JL; Dinglin XX; Chen LK
Asian Pac J Cancer Prev; 2012; 13(3):909-14. PubMed ID: 22631670
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for brain metastases in completely resected small cell lung cancer: a retrospective study to identify patients most likely to benefit from prophylactic cranial irradiation.
Zhu H; Bi Y; Han A; Luo J; Li M; Shi F; Kong L; Yu J
Radiat Oncol; 2014 Sep; 9():216. PubMed ID: 25239373
[TBL] [Abstract][Full Text] [Related]
40. Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases.
Hanke B; Jünger ST; Kirches E; Waldt N; Schreiber J; Lücke E; Franke S; Sandalcioglu IE; Warnke JP; Meisel HJ; Prell J; Scheller C; Braunsdorf WEK; Preusser M; Schildhaus HU; Mawrin C
Clin Neurol Neurosurg; 2021 Sep; 208():106841. PubMed ID: 34343913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
